Quarterly Statement Of Cash Flows

EnBio Holdings,Inc - Filing #7557367

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,603,312,000 JPY
2,613,769,000 JPY
Interest and dividends received
28,944,000 JPY
21,028,000 JPY
Interest paid
-125,601,000 JPY
-123,476,000 JPY
Net cash provided by (used in) operating activities
1,989,080,000 JPY
2,413,152,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,162,712,000 JPY
-1,164,847,000 JPY
Proceeds from sale of property, plant and equipment
JPY
3,501,000 JPY
Purchase of investment securities
-23,685,000 JPY
-119,413,000 JPY
Loan advances
-552,456,000 JPY
-97,190,000 JPY
Other, net
-17,246,000 JPY
-9,318,000 JPY
Net cash provided by (used in) investing activities
-1,770,420,000 JPY
-1,481,400,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,349,902,000 JPY
1,540,424,000 JPY
Repayments of long-term borrowings
-1,208,477,000 JPY
-1,649,252,000 JPY
Redemption of bonds
-35,000,000 JPY
-35,000,000 JPY
Purchase of treasury shares
JPY
-43,873,000 JPY
Dividends paid
-52,892,000 JPY
JPY
Net cash provided by (used in) financing activities
240,727,000 JPY
-534,925,000 JPY
Effect of exchange rate change on cash and cash equivalents
-2,368,000 JPY
-40,502,000 JPY
Net increase (decrease) in cash and cash equivalents
457,019,000 JPY
356,324,000 JPY
Cash and cash equivalents
2,798,635,000 JPY
2,341,616,000 JPY
1,985,292,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.